A purple and pink letter v on a white background.
September 17, 2020

Examining Consumer Sentiment For Personal Care And Aesthetic Services Post-COVID-19

What will the post-pandemic world look like? That’s impossible to determine, but recent research suggest that patient demand for aesthetic and beauty treatments is likely to return to pre-pandemic levels and possibly increase. What is driving this growth, and how can medical aesthetic providers respond to this opportunity?

According to statistics from Kantar, a data and consulting firm, “beauty therapy” was the most popular activity that consumers were excited to resume once COVID-19 lockdowns were lifted. The firm scanned social media mentions in March 2020 and found that beauty therapy beat other activities such as eating out, seeing friends, attending concerts, and travel.

Perhaps it’s not surprising that aesthetic treatments and other beautifying practices were top of mind for people throughout the initial COVID-19 shelter-in-place orders. During times of stress, aesthetic treatments can be a way of taking control over physical appearance and emotional well-being. Seeking medical aesthetic procedures is also a vote of confidence in the future, a reflection of the belief that even when times are uncertain and frightening, there will be brighter days ahead. 

While COVID-19 continues to impact the business landscape and many states still have various restrictions in place, recent statistics from RealSelf indicate that traffic and bookings through their website has returned to about 80% of pre-pandemic levels.

Gauging what patients will want in the months to come can help your aesthetic practice thrive. Interestingly, some products are seeing strong sales, including at home-beauty tools—such as face scrapers and facial steamers—serums, and skincare that helps block blue light.

What Patients Want Post-Pandemic

Looking at the big picture, what are your patients likely to want? First, many will want to feel safe when seeking a medical aesthetic treatment, which means that cleanliness and hygiene are of the utmost importance. Make sure patients are aware of the health and safety guidelines that your practice maintains—such as daily temperature checks for staff—and that you follow them rigorously. They should know that their well-being is your top priority. Furthermore, expect to see preventive health, safety and wellness as drivers of patient behavior well into the future.

Another aspect that patients are looking for is brands that make ethical choices; the emerging trend of “clean beauty” is evidence of this. People want to choose products and services from companies that are made from natural ingredients and care about more than the bottom line. Think about how you present your practice to potential patients. Do they feel that you care about them, and about making the world a better place? Communicating that vison may be critical to capture the attention of clean beauty consumers.

Keep in mind that many of your patients may have modified their beauty and skincare routines due to COVID-19. Highlight the ways in which aesthetic treatments can further enhance those routines. Emphasizing the advantages of your treatments—perhaps over a Zoom call—is another strategy to appeal to your patients’ current priorities.

Finally, recognize that many people value connection, and that digital tools such as social media and webinars can help you maintain this connection between in-person appointments. Even patients who are afraid to seek treatment right now may return once they feel safe, so look for techniques to stay in touch.

Helping Your Practice Prepare and Thrive

Want to learn more about how to prepare your practice for the post-pandemic landscape? Talk to one of the experts at Venus Concept. In addition to cutting-edge medical aesthetics devices, we offer a Practice Enhancement Program that can help you build and maintain a successful business—even during unprecedented times. For more information about how we can help your practice, contact us today.

July 28, 2026
TORONTO, July 28, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced it has entered into an exclusive distribution agreement with HIRONIC Co. Ltd. (“HIRONIC”), a KOSDAQ listed South Korean company specializing in medical aesthetic devices, pursuant to which the Company acquires the exclusive right to distribute HIRONIC’s Doublo 2.0 device in the United States and Canada. The “New Doublo 2.0” is a synergistic, multi-energy-based medical device platform for the face and body, equipped with two separate handpieces that enables clinics to offer customer Cold Plasma and RF microneedling treatments. The device has received 510(k) certification from the U.S. Food and Drug Administration, and the Company intends to make it available to customers in the United States during 2H 2026. Venus Concept will support future regulatory approval efforts in Canada for the device and any additional handpiece technologies for both regions. “HIRONIC is a global leader in developing innovative medical aesthetic technologies and we are excited for the new partnership, starting with the Doublo x Venus Signature Edition,” said Rajiv De Silva, Chief Executive Officer of Venus Concept. “With this device, we look forward to offering our customers an innovative, exclusive Cold Plasma and RF Microneedling platform. By combining these complementary technologies, the platform delivers synergistic effects from the epidermis to the dermis, enabling comprehensive skin rejuvenation by addressing multiple skin concerns and enhancing overall skin revitalization. The Doublo also complements our existing portfolio by enhancing the range of treatment modalities for a customizable treatment plan to address each patient’s skin needs. We aim to expand our partnership in the future to bring to our customers additional new and novel technologies from HIRONIC, once regulatory approvals have been obtained.” About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. Investor Relations Contact: Damian Yeung, CPA investorrelations@venus.ai View Full Article
May 22, 2026
Skin Cancer Awareness Month highlights prevention and early detection. Learn how dermatologists support care with advanced tools and treatments.
May 22, 2026
Skin cancer radiotherapy improves treatment precision and patient outcomes. Learn how dermatology clinics use it in modern care plans.